Yin Jin Selected Research

Yin Jin Research Topics

Disease

13	Neoplasms (Cancer) 11/2021 - 01/2014
6	Pancreatitis 12/2018 - 09/2012
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2015
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2015
4	Hyperthermia 03/2018 - 01/2018
3	Necrosis 12/2018 - 12/2013
2	Non-alcoholic Fatty Liver Disease 11/2021 - 09/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2018
2	Liver Neoplasms (Liver Cancer) 03/2018 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 03/2018 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 01/2016
2	Carcinoma (Carcinomatosis) 09/2016 - 01/2015
2	Acute Necrotizing Pancreatitis 05/2012 - 11/2010
1	Hyperlipidemias (Hyperlipidemia) 11/2021
1	Insulin Resistance 11/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 11/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	COVID-19 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pruritus (Itching) 01/2021
1	Carcinogenesis 01/2021
1	Adenocarcinoma of Lung 06/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Hemorrhage 12/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2018
1	Cholangiocarcinoma 01/2018
1	Residual Neoplasm 01/2018
1	Polyps 09/2017
1	Adenomatous Polyps 09/2017
1	Hypoproteinemia 07/2015
1	Colonic Neoplasms (Colon Cancer) 06/2015
1	Brain Infarction 02/2015
1	Stroke (Strokes) 02/2015

Drug/Important Bio-Agent (IBA)

11	MelatoninIBA 01/2019 - 11/2010
5	Taurocholic Acid (Sodium Taurocholate)IBA 12/2018 - 05/2012
3	Ganciclovir (Cytovene)FDA LinkGeneric 03/2018 - 01/2018
3	Phosphates (Orthophosphate)IBA 03/2018 - 01/2018
3	Thymidine KinaseIBA 03/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2018
2	LuciferasesIBA 03/2018 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 01/2018
2	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2015
2	Atrial Natriuretic Factor (ANF)IBA 05/2012 - 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	LipidsIBA 11/2021
1	dorsomorphinIBA 11/2021
1	Caspase 3 (Caspase-3)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Sterol Regulatory Element Binding Protein 1IBA 11/2021
1	epimedii flavoneIBA 11/2021
1	icariinIBA 11/2021
1	oxidized low density lipoproteinIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	VaccinesIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	ProteomeIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	CholesterolIBA 01/2021
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 06/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2019
1	Transcription Factor CHOPIBA 12/2018
1	TrypsinIBA 12/2018
1	CytokinesIBA 01/2018
1	Green Fluorescent ProteinsIBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	InterleukinsIBA 01/2018
1	Amylases FDA Link 01/2018
1	ORALIT (ORS)IBA 09/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2016
1	Contrast MediaIBA 09/2016
1	Capsules (Microcapsules)IBA 09/2016
1	Lipid NanoparticlesIBA 09/2016
1	AzoxymethaneIBA 09/2016
1	AcidsIBA 09/2016
1	Dextran SulfateIBA 09/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2016
1	Gadolinium DTPA (Magnevist)FDA Link 09/2016
1	GadoliniumIBA 09/2016
1	isothiocyanic acidIBA 09/2016
1	stearylamineIBA 09/2016
1	C-Reactive ProteinIBA 07/2015
1	Cetuximab (Erbitux)FDA Link 06/2015

Therapy/Procedure

6	Therapeutics 11/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2015
1	Percutaneous Collagen Induction 01/2021
1	Immunotherapy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Telerehabilitation 02/2015